Hong Li

Hong Li is a Director in ClinPharm/Pharmacometrics at Pfizer, a role they have held since 2023. They previously served as a Principal Clinical Pharmacologist, Senior Clinical Pharmacologist, and Associate Director at Seagen from 2020 to 2023. Prior to that, Hong worked as a Scientist in Quantitative Pharmacology at Amgen from 2012 to 2014 and completed a postdoctoral research fellowship focused on Population PKPD modeling at the University at Buffalo from 2009 to 2012. Hong earned a Ph.D. in Pharmaceutical Sciences from the University of Florida, where they also obtained an M.S. in Statistics, and a B.S. in Biotechnical Pharmaceutics from China Pharmaceutical University.